Please login to the form below

Not currently logged in
Email:
Password:

Lucid Group

This page shows the latest Lucid Group news and features for those working in and with pharma, biotech and healthcare.

Is agile working benefiting the employee or the organisation?

Is agile working benefiting the employee or the organisation?

HR director for Lucid Group. 11th April 2018.

Latest news

  • Lucid’s first class of 2018 graduates from Lucid’s Futures Academy

    Four graduates complete an eight-week training course. The Lucid Futures Academy, a graduate programme formed by medical communications company Lucid Group, has seen four of its new hires graduate after ... The programme, which saw employees mentor

  • Lucid picks up rare disease and orphan drugs trophy at PMEA 2017 Lucid picks up rare disease and orphan drugs trophy at PMEA 2017

    Judges praised the AbbVie project for its impressive reach. Lucid picked up the award for Excellence in Rare Diseases and Orphan Drugs at this year’s PMEA Awards, which were hosted ... AbbVie employees, with support from Lucid Group, developed

  • Lucid launches rare and specialist disease agency Lucid launches rare and specialist disease agency

    Lucid launches rare and specialist disease agency. Vivid MedComms will be headed by Alison Cantle. ... UK-based Lucid Group, has opened Vivid Medcomms, a new agency that will focus on rare diseases and be based in Buckinghamshire, UK.

  • Signal strength Signal strength

    The best communications programmes start by identifying the patient outcomes they want to improve and work backwards from there, ”says Dennis O’Brien, CEO, Lucid Group.

  • 90TEN named Communiqué Consultancy of the Year 2017 90TEN named Communiqué Consultancy of the Year 2017

    90TEN marked a successful night at the 2017 Comm uniqué Awards, picking up Communications Consultancy of the Year and the Lucid Group Award for Medical Education Consultancy of the Year. ... Communications, Porterhouse Medical and Rock Unlimited to take

More from news
Approximately 11 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Six degrees of participation Six degrees of participation

    Dennis O’Brien, CEO, Lucid Group, agrees. “Pharma has been on a journey of trying to understand patients and has recognised that, at times, patients treat HCPs with a deference that

  • A marathon and a sprint A marathon and a sprint

    There’s a more even share of brand leadership across the disciplines, ”says Dennis O’Brien, CEO, Lucid Group. ... At Lucid, we did it with oncology KOLs at a European congress.

  • Flight path: the long-haul journey Flight path: the long-haul journey

    The way pharma does strategic planning today is much more inclusive - it’s bigger, broader, grander, ”says Dennis O’Brien, CEO, Lucid Group.

  • Stepping out Stepping out

    Lucid Group. ... Sustainable behaviour change is a group dance that never ends. Achieving it requires complex choreography to correct old habits and bad footwork on all sides of the dance floor.

  • Signal strength Signal strength

    The best communications programmes start by identifying the patient outcomes they want to improve and work backwards from there, ”says Dennis O’Brien, CEO, Lucid Group.

More from intelligence
Approximately 4 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 4 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics